louisakewell, Author at European Medical Journal - Page 52 of 153

Modern Indications for Endoscopic Endonasal Surgery

Endoscopic endonasal surgery has become a standard procedure for functional treatment of benign pathologies. Materials and improved surgeon skills have…

microRNAS in Therapy Resistance of Breast Cancer

Breast cancer is one of the deadliest cancer types worldwide and consists of several subtypes differing in their molecular characteristics; each subtype…

Gastrointestinal Stromal Tumours: A Review on Genetics, Pathology, Risk Stratification, Clinical Characteristics, Investigation, and Treatment

Gastrointestinal stromal tumours (GISTs) are the most common mesenchymal tumours of the gastrointestinal tract, arising from the interstitial cells of…

Somatic Mutations in Myelodysplastic Syndrome Patients in the Context of Allogeneic Stem Cell Transplantation

Myelodysplastic syndrome (MDS) is a heterogeneous group of myeloid disorders. Allogeneic stem cell transplantation (alloSCT) is the therapeutic approach…

Palliative Radiotherapy and Hormonal Deprivation for Prostate Cancer Induced Urinary Obstruction at a Sub-Saharan Tertiary Hospital

The occurrence of bladder outlet obstruction (BOO) in men with prostate cancer is common. Although relieving the obstruction may not change prognosis, it…

EMJ

Will Biosimilars Change the Treatment Paradigm in Psoriasis?

This symposium took place on 29th September 2016 as a part of the European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria…

EAACI Sheds Light on Recent Developments in Severe Asthma

United Kingdom, November 17, 2016 – The European Academy of Allergy and Clinical Immunology (EAACI) hosts today in Manchester the 3rd International…

Introducing EMJ Dermatology 4.1

United Kingdom, November 15, 2016: Hello and welcome to this year’s EMJ Dermatology eJournal, updating the field with cutting-edge developments within…

Will Biosimilars Change the Treatment Paradigm in Psoriasis?

Prof Augustin opened the meeting and reviewed the use of systemic treatments recommended for moderate-to-severe psoriasis. Data indicating a lack of…

Immunopathogenesis of Leprosy: A Model for T Cell Anergy

Leprosy is a model disease for understanding human immune responses underlying diseases caused by intracellular pathogens, as well as providing valuable…